We have examined and analyzed the status of policy, R＆D investments, patents and market share of physiological signal measurement technologies for major countries including Korea, the United States, European Union and Japan. Korea is generally inferior to the others in terms of priority of industrial policy, R＆D investment, number of patents, technological level and world market share. However, Korea could recover competitiveness, with intensive government supports for this technology.